OPEN END TURBO PUT-OPTIONSSCHEIN MIT SL - CVS HEALTH Stock

Certificat

DE000SW9WJG4

Real-time Boerse Frankfurt Warrants 08:32:49 2024-06-27 am EDT
1.08 EUR +14.89% Intraday chart for OPEN END TURBO PUT-OPTIONSSCHEIN MIT SL - CVS HEALTH
Current month-10.48%
1 month-30.88%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-27 1.08 +14.89%
24-06-26 0.94 +3.30%
24-06-25 0.91 +10.98%
24-06-24 0.82 -6.82%
24-06-21 0.88 -1.12%

Real-time Boerse Frankfurt Warrants

Last update June 27, 2024 at 08:32 am EDT

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellPUT
Underlying CVS HEALTH CORPORATION
IssuerLogo Issuer Société Générale Société Générale
WKN SW9WJG
ISINDE000SW9WJG4
Date issued 2024-05-03
Strike 70.64 $
Maturity Unlimited
Parity 10 : 1
Emission price 1.36
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.61
Lowest since issue 0.8
Spread 0.02
Spread %1.82%

Company Profile

CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows: - medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.; - retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®); - medical benefits management (25.8%); - other (0.1%).
Sector
-
More about the company

Ratings for CVS Health Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: CVS Health Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
60.63 USD
Average target price
69.1 USD
Spread / Average Target
+13.96%
Consensus